AI-ACCELERATED DRUG DISCOVERY

Focused On-demand Library for S-formylglutathione hydrolase

Available from Reaxense
Predicted by Alphafold

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.

Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.

In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.

Our top-notch dedicated system is used to design specialised libraries for enzymes.

 Fig. 1. The sreening workflow of Receptor.AI

This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.

Our library stands out due to several important features:

  • The Receptor.AI platform compiles comprehensive data on the target protein, encompassing previous experiments, literature, known ligands, structural details, and more, leading to a higher chance of selecting the most relevant compounds.
  • Advanced molecular simulations on the platform help pinpoint potential binding sites, making the compounds in our focused library ideal for finding allosteric inhibitors and targeting cryptic pockets.
  • Receptor.AI boasts over 50 tailor-made AI models, rigorously tested and proven in various drug discovery projects and research initiatives. They are crafted for efficacy, dependability, and precision, all of which are key in creating our focused libraries.
  • Beyond creating focused libraries, Receptor.AI offers comprehensive services and complete solutions throughout the preclinical drug discovery phase. Our success-based pricing model minimises risk and maximises the mutual benefits of the project's success.

partner

Reaxense

upacc

P10768

UPID:

ESTD_HUMAN

Alternative names:

Esterase D; Methylumbelliferyl-acetate deacetylase

Alternative UPACC:

P10768; Q5TBU8; Q5TBV0; Q5TBV2; Q9BVJ2

Background:

S-formylglutathione hydrolase, also known as Esterase D and Methylumbelliferyl-acetate deacetylase, plays a crucial role in the detoxification of formaldehyde, a potentially harmful compound. This serine hydrolase enzyme catalyzes the conversion of S-formylglutathione to formate and glutathione, a key reaction in cellular defense mechanisms against formaldehyde-induced toxicity.

Therapeutic significance:

Understanding the role of S-formylglutathione hydrolase could open doors to potential therapeutic strategies. Its pivotal function in detoxifying formaldehyde suggests its significance in maintaining cellular health and preventing diseases associated with formaldehyde exposure.

Looking for more information on this library or underlying technology? Fill out the form below and we'll be in touch with all the details you need.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.